HOME >> BIOLOGY >> NEWS
Work with cancer-related proteins garners National Foundation for Cancer Research grant

NASHVILLE, Tenn. -- The National Foundation for Cancer Research has awarded new research funding to support work at the Vanderbilt-Ingram Cancer Center to better understand the differences between two related proteins involved in tumor development as well as pain and inflammation.

The $300,000, three-year grant will support basic cancer research by Lawrence J. Marnett, Ph.D., in Vanderbilt-Ingram's A.B. Hancock Memorial Research Center to identify and examine functional biochemical differences between cyclooxygenase (COX) 1 and 2. COX-2 in particular appears to play an important role in cancer development and is expressed in many human tumors including lung, colon, breast, prostate, bladder, pancreas, and esophagus.

"The National Foundation for Cancer Research provides support for innovative and high risk research that has potential for the sorts of discoveries that push science into new areas," said Marnett, Mary Geddes Stahlman Professor of Cancer Research. Marnett is director of the Hancock center and associate director for basic science programs at the Vanderbilt-Ingram Cancer Center. "Funding for that type of work is often quite difficult to come by, so we are very appreciative of the National Foundation for Cancer Research's support."

The cyclooxygenases are the targets for aspirin and similar non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. COX-1's job is to produce the prostaglandins that protect the stomach lining from irritation; COX-2 becomes active under specific conditions to produce prostaglandins that cause inflammation, pain and promote tumor development and growth. Because aspirin and NSAIDs target both COX-1 and COX-2, they often cause stomach irritation along with providing pain and inflammation relief.

New drugs that target only COX-2, without affecting COX-1, have recently been developed. They are initially being marketed as treatments for arthritis, but they are also being studied at Vanderbilt-Ingram for their
'"/>

Contact: Cynthia Manley
cynthia.manley@mcmail.vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
25-Oct-2000


Page: 1 2 3

Related biology news :

1. Scientists identify molecular structure of cancer-related proteins
2. New molecular link key to cellular proteins involved in cancer progression, other diseases
3. New dye directly reveals activated proteins in living cells
4. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
5. Scientists discover proteins involved in spread of HIV-1 infection
6. New mechanism for display of foreign proteins to immune system
7. Scientists visualise cellular handmaiden that restores shape to proteins
8. Hopkins scientists use blood proteins to detect ovarian cancer
9. Viral proteins may prevent bacterial infections
10. Misfiring proteins tied to inflammation and sick feeling of type 2 diabetics
11. Good bacteria trigger proteins to protect the gut

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2019)... ... January 03, 2019 , ... ... cell culture models into their drug discovery research workflows with biology ranging from ... in vivo relevancy of in vitro studies, they create several challenges that need ...
(Date:12/27/2018)... ... December 27, 2018 , ... uBiome, the leader in microbial ... JP Morgan 37th Annual Healthcare Conference in San Francisco, which brings together industry ... community. , Since its origin in 1983, the JP Morgan Healthcare Conference ...
(Date:12/20/2018)... TRIANGLE PARK, N.C. (PRWEB) , ... December 20, ... ... have been enhanced through upgraded processes and the completion of a new usability/observation ... Evaluations with the goal of ensuring medical devices and drug delivery devices/combination products ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... 2018 , ... Microbial Discovery Group LLC (MDG) has expanded ... of their strategic plan and an important milestone in increasing their Bacillus fermentation ... MDG within the $44 Billion human probiotic market. This plan is a vital ...
(Date:12/5/2018)... ZOETERMEER, Netherlands (PRWEB) , ... December 05, 2018 , ... ... last week paid tribute to in the European Parliament by Carlos Moedas, the European ... High-Level Conference EU Research and Innovation in Our Daily Lives, Commissioner Moedas spoke at ...
(Date:11/29/2018)... ... ... RAGS, today announced the closing of a $1.5 million Second Seed round investment. ... board member Jeremy Andrus, CEO of Traeger Grills, as well as James Ho of ... to accelerate its growth and expand the product line. RAGS has now raised a ...
(Date:11/26/2018)... ... 2018 , ... USARAD Holdings Inc., the leading US Joint ... Radiologic founders) among other healthcare investors exhibits at the Radiological Society of North ... The company is proud to announce a 10 year anniversary since its formation ...
Breaking Biology Technology:
Cached News: